BioStock: Can we reverse diabetes? – Abarceo Pharma aims to develop the solution of the future
World Diabetes Day on November 14 raised awareness of diabetes as one of the greatest public health challenges of our time, along with the importance of ensuring access to adequate care for everyone affected. Claes Wollheim, founder of Abarceo Pharma, has dedicated his career to diabetes research. In an interview, he discusses the challenges within the field and how Abarceo aims to tackle them by restoring the body’s natural insulin production in beta cells.
Watch the interview at biostock.se:
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se